维普期刊资源整合服务平台（V6.5）

116篇 您的检索式：作者名="Karrison"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Changing etiologies of unexplained adult nephrotic syndrome:a comparison of renal biopsy findings from, 1976-1979 and, 1995- 1997 显示文摘	Haas M Meehan SM Karrison TG	1997	Am J Kidney Dis1997，30，5：	1
2	Critical evaluation of diagnostic aids for the detection of oral cancer 显示文摘	Lingen MW Kalmar JR Karrison T	2008	Oral Oncol2008，44，1：	1
3	Fetal loss associated with excess thyroid hormone exposure 显示文摘	Anselmo J Caod Karrison T	2004	J American Med Association2004，292，6：	1
4	Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small - cell lung cancer显示文摘	Karrison TG Maitland ML Stadler WM	2007	1 Natl CancerInst2007，99，19：	1
5	Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976 - 1979 and 1995 - 1997显示文摘	Haas M Meehan SM Karrison TG & Spargo BH	1997	Am J Kidney Dis1997，30，5：	1
6	HLA - G genotypes and pregnancy outcome in couples with un- explained recurrent miscarriages 显示文摘	Aldrich CL Stephenson MD Karrison T	2001	Mol Hum Reprod2001，7，12：	1
7	A phase Ⅱ trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer 显示文摘	Argiris A Cohen E Karrison T	2006	Cancer Biol Ther2006，5，7：	1
8	Ambulatory monitoring detects sorafenib induced blood pressure elevations on the first day of treatment 显示文摘	Maitland ML Kasza KE Karrison T	2009	Clin Cancer Res2009，15，19：	1
9	Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck:a phase Ⅰ/Ⅱ study显示文摘	Cohen EE Davis DW Karrison TG	2009	Lancet Oncol2009，10，3：	1
10	Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck:a phase Ⅰ/Ⅱ study显示文摘	COHEN E E DAVIS D W KARRISON T G		0，，03：	1
11	Multicenter,doubleblind,placebo-controlled,randomized phase Ⅱ trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma显示文摘	Kindler HL Karrison TG Gandara DR		0，，20：	1
12	Dormancy of mammary carcinoma after mastectomy显示文摘	Karrison T G Ferguson D J Meier P	1999	J Natl Cancer Inst1999，91，1：	1
13	Ambulatory monitoring detects sorafenib induced blood pressure elevations on the first day of treatment显示文摘	Maitland ML Kasza KE Karrison T	2009	Clin Cancer Res2009，15，19：	1
14	Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patients显示文摘	Weir B Disney L Karrison T	2002	J Neurosurg2002，96，1：	1
15	Changing etiologies of unexplained adult nephrotic syndrome:a comparison of renal biopsy findings from1976-1979and1995-1997显示文摘	Haas M Meehan SM Karrison T	1997	Am J Kidney Dis1997，30，5：	1
16	Factors influencing neonatal outcomes in thevery-low-birth-weight fetus(<1500 grams)with a breech presentation显示文摘	CIBILS LA KARRISON T BROWN L	1994	Am J Obstet Gynecol1994，171，1：	1
17	Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors显示文摘	Dolan M E Posner M Karrison T	2002	Clin Cancer Res2002，8，8：	1
18	Erlotinib and bevacizumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck:a phaseⅠ/Ⅱstudy显示文摘	Cohen EE Davis DW Karrison TG		0，，：	1
19	Fetal loss associated with excessthyroid hormone exposure显示文摘	Anselmo J Cao D Karrison T	2004	J American Med Associat ion2004，292，6：	1
20	Erlotinib and bevacizum- ab in patients with recurrent or metastatic squamous-cell Carcinoma of the head and neck: a phase I/II study 显示文摘	Cohen EE Davis DW Karrison TG	2009	The Lancet Oncology2009，10，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示